Effect of barberry fruit (Berberis Vulgaris) on serum glucose and lipids in streptozotocin-diabetic rats

Pharmacologyonline

Volumn 1, Issue , 2011, Pages 809-817

  Hajzadeh, M A R ^a   Rajaei, Z ^a   Shafiee, S ^b   Alavinejhad, A ^b   Samarghandian, S ^b   Ahmadi, M ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberis vulgaris; Diabetes mellitus; Hyperglycemia; Hyperlipidemia; Rat

Indexed keywords

BERBERIS VULGARIS EXTRACT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BERBERIS; BERBERIS VULGARIS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; FRUIT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

EID: 79955622194     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Peter P, Nuttall SL, Kendall MJ. Insulin resistance--the new goal! J Clin Pharm Ther 2003; 28: 167-74.
2. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl 2002; 3: 47-51.
3. Reasner CA. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J Cardiovasc Pharmacol 2008; 52: 136-144.
4. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001; 414: 821-827.
5. Zhang BB, Moller DE. New approaches in the treatment of type 2 diabetes. Curr Opinion Chem Biol 2000; 4: 461-467.
6. Pushparaj P, Tan CH, Tan BKH. Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol 2000; 72: 69-76.
7. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A, Contreras- Weber CC, Flores-Saenz JL. Study of the anti-hyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol 1998; 61: 101-110.
8. Singh SK, Kesari AN, Gupta RK, Jaiswal D, Watal G. Assesment of antidiabetic potential of Cynodon dactylon extract in streptozotocin diabetic rats. J Ethnopharmacol 2007; 114: 174-179.
9. Kameswararao B, Kesavulu MM, Apparao C. Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats. Fitoterapia 2003; 74: 7-13.
10. Zargari A. Medicinal Plants, Tehran University Press, Tehran; 1983. Vol. 1, p. 68.
11. Aynehchi Y. Pharmacognosy and Medicinal Plants of Iran. Tehran University Press, Tehran; 1986. p. 1041.
12. Nafissi A. Foods and Drinks' Properties. Isfahan University Press, Isfahan; 1990. p. 150.
13. Kupeli E, Kosar M, Yesilada E, Husnu K, Baser C. A comparative study on the anti- inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sciences 2002; 72: 645-657.
14. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004; 25: 496-502.
15. Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizome. Biol Pharm Bull 2005; 28: 1431-7.
16. Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, Xie YY. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 2003; 69: 632-636.
17. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, et al. Berberine is a novel cholesterol- lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10:1344-1351.
18. Shamsa F, Ahmadiani A, Khosrokhavar R. Antihistaminic and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol 1999; 64: 161-166.
19. Szkudelski T. The mechanism of alloxan and streptozotocin action in ß cells of the rat pancreas. Physiol Res 2001; 50: 537-546.
20. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008; 704045: 2008.
21. Ar, Rajab A, Ahren B. Long-term diabetogenic effect of streptozotocin in rats. Pancreas 1993; 8: 50-57.
22. Chakravarthy BK, Gupta S, Gambhir SS, Gode KD. Pancreatic beta cell regeneration: A novel antidiabetic mechanism of Petercarpus marsupium. Ind J Pharmacol 1980; 12: 123-128.
23. Ananthan R, Latha M, Pari L, Baskar C, Narmatha V. Modulatory effects of Gymnema montanum leaf extract on alloxan induced stress oxidative in wistar rats. Nutrition 2004; 20: 280-285.
24. Bopanna KN, Kannan J, Gadgil S, Balaraman R, Rathod SP. Antidiabetic and antihyperglycemic effects of Neem seed kernel powder alloxan diabetic rabbits. Ind J Pharmacol 1997; 29: 162-167.
25. Chorvathova V, Bobek P, Ginter E, Klavanova J. Effect of oyster fungus on glycemia and cholesterolemia in rats with insulin-dependent diabetes. Physiol Res 1993; 42: 175-179.
26. Lu SS, Yu YL, Zhu HJ, Liu XD, Liu L, Liu YW, Wang P, Xie L, Wang G. Berberine promotes glucacon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol 2009; 200: 159-165.
27. Kim SH, Shin EJ, Kim ED, Bayaraa T, Frost SC, Hyun CK. Berberine avtivates GLUT1- mediated glucose uptake in 3T3-L1 adipocytes. Biol Pharm Bull 2007; 30: 2120-2125.
28. Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, Chen J. Effects of berberine on glucose metabolism in vitro. Metabolism 2002; 51: 1439-1443.
29. Tang LQ, Wei W, Chenb LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006; 108: 109-115.
30. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006; 55: 2256-2264.